News & Updates
Showing Cardiology articles
Showing
Show Multimedia Only

SGLT2is reduce serious hyperkalaemia risk in T2D, CKD patients
23 Jun 2022
byAudrey Abella
Sodium-glucose cotransporter 2 inhibitors (SGLT2is) consistently reduced the risk of serious hyperkalaemia (serum potassium [K+] ≥6.0 mmol/L) without increasing the risk of hypokalaemia (serum K+ ≤3.5 mmol/L) in individuals with type 2 diabetes (T2D) at high cardiovascular (CV) risk, or in those with chronic kidney disease (CKD), a meta-analysis has shown.
23 Jun 2022

Estimated pulse wave velocity, socioeconomic status predict stroke risk in men
18 Jun 2022
Estimated pulse wave velocity (ePWV) and socioeconomic status (SES) independently contribute to a higher risk of stroke in men, and the relationship between elevated ePWV and increased stroke risk remains whether an individual has high or low SES, according to a study.
18 Jun 2022






